stars 1 stars 2 stars 3

Ideal Cures Pvt. Ltd. is a world’s leading manufacturer and supplier of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. The product portfolio comprises INSTACOAT ready-to-use film coating systems, INSTANUTE coating technology for nutraceuticals and dietary supplements, ECOPOL range of Pharma Acrylic Polymer’s, ECOCOOL brand of cooling compounds, ESPHERES range of sugar, MCC, silicon & calcium carbonate spheres. We have four manufacturing plants located in India at Vasai, Jammu, Sikkim and Khambhat and one in the US at Virginia along with two modern R&D facilities at Mumbai and Vasai. Our state-of-the-art manufacturing facilities are strongly backed by our technical services, value added products and global regulatory support including maintenance of US Drug Master Files for almost all our products. Our highly qualified and experienced technical team provides technical support to the customers whenever required. We have a long term commitment to quality, research and development, sufficient capacity and adherence to current good manufacturing practices. By virtue of our vast experience with regards to pharmaceutical solid oral dosage forms, we possess in-house capabilities in the development and use of various excipients thereby creating a niche in Pharmaceutical, Herbal, Nutraceutical & Veterinary industries.

Website http://www.idealcures.com/
Revenue $84.4 million
Employees 165 (120 on RocketReach)
Founded 1999
Technologies
Industry Pharmaceutical Manufacturing, Chemicals, Enteric Coating, Chemicals, Petrochemicals, Glass & Gases, Film Coating, Manufacturing, Taste Masking Solutions, Cooling Boosters
Web Rank 7 Million
Keywords Pharmaceutical Excipients, Drug Manufacturing, Pharmaceutical Ingredients, Pharmaceutical Manufacturing, Solid Oral Dosage Forms, Excipient Supplier, Pharma Excipients, Coating Supplier, Pharmaceutical Coatings, Pharmaceutical Supplier, Coating Materials, Drug Development, Dosage Forms, Drug Delivery Systems, Coating Solutions
Competitors BASF, Dow, Merck Group, DuPont, Evonik, FMC Corporation, Ashland, Nouryon, Croda, Colorcon® +32 more (view full list)
SIC SIC Code 28 Companies

Ideal Cures Questions

The Ideal Cures annual revenue was $84.4 million in 2026.

Dillip Swain is the COO of Ideal Cures.

120 people are employed at Ideal Cures.

The SIC codes for Ideal Cures are [28].

Top Ideal Cures Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users